Cancer-Savvy New CMO Eager to Extend Astellas’ Oncology Portfolio, Bag Speedy Approval

October 28, 2022
Astellas CMO Tadaaki Taniguchi After raising its profile with urological cancer meds, Astellas Pharma is now working to expand its oncology pipeline into gastric cancer and other tumor types. The company’s newly appointed chief medical officer is keen to spearhead...read more